(a) Tautomycin and 1a prevent the formation of CGG repeat foci. Transfected cells were treated with vehicle, 20 μM 1a, or 5 μM tautomycin was added to cells. After 24 h, 100 DsRed-positive cells were analyzed for the presence of nuclear foci for each condition. 94 ± 1.4, 25 ± 4.9, and 12 ± 4.2% of nuclei contained foci with vehicle, 1a, and tautomycin, respectively. Data shown are mean and s.e.m. values for three independent experiments.
(b) Representative images of nuclei after 24 h of treatment. DsRed-Max was used as a transfection control.
(c) Preexisting (CGG)60-Spinach2 foci are disaggregated by tautomycin. COS-7 cells expressing (CGG)60-Spinach2 foci were incubated with vehicle, 20 μM 1a, or 5 μM tautomycin and imaged for 2 h after drug treatment. Scale bar 10 μm.